Investigational Drug Details
Drug ID: | D224 |
Drug Name: | Metadoxine |
Synonyms: | Pyridoxine mixture with Pyrrolidonecarboxylic Acid; Pyridoxine pyroglutamate |
Type: | Chemical drug |
DrugBank ID: | DB16554 |
DrugBank Description: | -- |
PubChem ID: | 115198 |
CasNo: | 74536-44-0 |
Repositioning for NAFLD: | No |
SMILES: | C(=O)(O)[C@H]1NC(=O)CC1.C(O)c1c(CO)cnc(c1O)C |
Structure: |
|
InChiKey: | RYKKQQUKJJGFMN-HVDRVSQOSA-N |
Molecular Weight: | 298.295 |
DrugBank Targets: | -- |
DrugBank MoA: | -- |
DrugBank Pharmacology: | -- |
DrugBank Indication: | -- |
Targets: | -- |
Therapeutic Category: | Antialcoholic drug |
Clinical Trial Progress: | Phase 3 suspended (NCT02541045: lack of resources to finance the project) |
Latest Progress: | Under clinical trials |

Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
---|---|---|---|---|---|---|---|
L0265 | NCT02051842 | Phase 4 | Unknown status | No Results Available | January 2016 | January 31, 2019 | Details |
L0867 | NCT02541045 | Phase 3 | Not recruiting | No Results Available | 31/08/2015 | 7 September 2021 | Details |
Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
---|
Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
---|
Article ID | PMID | Source | Title | |
---|---|---|---|---|
A12660 | 30341231 | Postgrad Med J | Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis. | Details |
A20754 | 25755546 | J Clin Exp Hepatol | Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial. | Details |
A28109 | 16398154 | Orv Hetil | [The therapeutic effect of metadoxine on alcoholic and non-alcoholic steatohepatitis]. | Details |
A28443 | 14708419 | J Int Med Res | A new approach to drug therapy in non-alcoholic steatohepatitis (NASH). | Details |
A47355 | 12940921 | Aliment Pharmacol Ther | Review article: Nutritional therapy in alcoholic liver disease. | Details |
A48832 | 27148681 | Minerva Med | Treatment of alcohol use disorder patients affected by liver cirrhosis and/or hepatocellular carcinoma awaiting liver transplantation. | Details |